Skip to main content
logo
Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.6001
-0.0712 (-10.61%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Cytosorbents Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3840506068182
Market Cap Growth
-31.10%-19.54%-17.13%-10.98%-62.87%-47.12%
Enterprise Value
60.5562.4773.0661.5263.63143.29
Last Close Price
0.600.640.911.111.554.19
PE Ratio
--4.92-2.39-1.71-2.07-7.35
PS Ratio
1.021.081.401.941.954.22
PB Ratio
6.386.804.492.561.912.91
P/TBV Ratio
6.336.744.462.111.912.90
P/FCF Ratio
---3.39-2.71-1.97-10.32
P/OCF Ratio
---3.46-2.78-2.40-13.01
EV/Sales Ratio
1.631.692.051.981.833.32
EV/EBITDA Ratio
--4.24-4.86-2.06-2.09-6.63
EV/EBIT Ratio
--4.24-4.35-1.93-2.02-6.30
EV/FCF Ratio
---4.97-2.77-1.85-8.12
Debt / Equity Ratio
4.844.842.380.660.510.21
Debt / EBITDA Ratio
-1.97-1.97-1.79-0.61-0.60-0.64
Debt / FCF Ratio
---1.83-0.82-0.53-0.78
Net Debt / Equity Ratio
3.873.872.130.18-0.11-0.61
Net Debt / EBITDA Ratio
-1.55-1.55-1.57-0.140.131.77
Net Debt / FCF Ratio
---1.60-0.190.112.17
Asset Turnover
0.420.810.710.540.450.48
Inventory Turnover
2.642.643.432.673.392.97
Quick Ratio
1.421.421.081.442.864.14
Current Ratio
2.132.132.201.813.484.70
Return on Equity (ROE)
-96.39%-96.39%-119.80%-99.38%-67.00%-34.64%
Return on Assets (ROA)
-30.72%-30.72%-30.94%-53.51%-39.94%-24.61%
Return on Invested Capital (ROIC)
-44.30%-44.30%-49.76%-105.11%-109.45%-133.49%
Return on Capital Employed (ROCE)
-40.96%-40.96%-43.90%-69.12%-48.74%-29.23%
Earnings Yield
-21.75%-20.34%-41.76%-58.56%-48.39%-13.60%
FCF Yield
-0.00%-29.49%-36.86%-50.75%-9.69%
Buyback Yield / Dilution
-15.85%-14.32%-21.90%-2.49%-0.49%-11.70%
Total Shareholder Return
-15.85%-14.32%-21.90%-2.49%-0.49%-11.70%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q